{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:56:25Z","timestamp":1792727785807,"version":"4.5.0"},"reference-count":42,"publisher":"American Association for Cancer Research (AACR)","issue":"6","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>While there is an increasing role of ultrasound for breast cancer screening in patients with dense breast, conventional anatomical ultrasound lacks sensitivity and specificity for early breast cancer detection. In this study, we assessed the potential of ultrasound molecular imaging using clinically translatable vascular endothelial growth factor receptor type 2 (VEGFR2)-targeted microbubbles (MBVEGFR2) to improve the diagnostic accuracy of ultrasound in earlier detection of breast cancer and ductal carcinoma in situ (DCIS) in a transgenic mouse model [FVB\/N-Tg(MMTV-PyMT)634Mul]. In vivo binding specificity studies (n = 26 tumors) showed that ultrasound imaging signal was significantly higher (P &amp;lt; 0.001) using MBVEGFR2 than nontargeted microbubbles and imaging signal significantly decreased (P &amp;lt; 0.001) by blocking antibodies. Ultrasound molecular imaging signal significantly increased (P &amp;lt; 0.001) when breast tissue (n = 315 glands) progressed from normal [1.65 \u00b1 0.17 arbitrary units (a.u.)] to hyperplasia (4.21 \u00b1 1.16), DCIS (15.95 \u00b1 1.31), and invasive cancer (78.1 \u00b1 6.31) and highly correlated with ex vivo VEGFR2 expression [R2 = 0.84; 95% confidence interval (CI), 0.72\u20130.91; P &amp;lt; 0.001]. At an imaging signal threshold of 4.6 a.u., ultrasound molecular imaging differentiated benign from malignant entities with a sensitivity of 84% (95% CI, 78\u201388) and specificity of 89% (95% CI, 81\u201394). In a prospective screening trail (n = 63 glands), diagnostic performance of detecting DCIS and breast cancer was assessed and two independent readers correctly diagnosed malignant disease in more than 95% of cases and highly agreed between each other [intraclass correlation coefficient (ICC) = 0.98; 95% CI, 97\u201399]. These results suggest that VEGFR2-targeted ultrasound molecular imaging allows highly accurate detection of DCIS and breast cancer in transgenic mice and may be a promising approach for early breast cancer detection in women. Cancer Res; 73(6); 1689\u201398. \u00a92012 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-12-3391","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T21:11:43Z","timestamp":1358457103000},"page":"1689-1698","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Earlier Detection of Breast Cancer with Ultrasound Molecular Imaging in a Transgenic Mouse Model"],"prefix":"10.1158","volume":"73","author":[{"given":"Sunitha V.","family":"Bachawal","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine; 2Departments of Pathology, Stanford University, Stanford; and Veterans Affairs Palo Alto Health Care System, Palo Alto; 3Department of Health, Research & Policy, Stanford University, Stanford, California; and 4Bracco Suisse SA, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin C.","family":"Jensen","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine; 2Departments of Pathology, Stanford University, Stanford; and Veterans Affairs Palo Alto Health Care System, Palo Alto; 3Department of Health, Research & Policy, Stanford University, Stanford, California; and 4Bracco Suisse SA, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie M.","family":"Lutz","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine; 2Departments of Pathology, Stanford University, Stanford; and Veterans Affairs Palo Alto Health Care System, Palo Alto; 3Department of Health, Research & Policy, Stanford University, Stanford, California; and 4Bracco Suisse SA, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv S.","family":"Gambhir","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine; 2Departments of Pathology, Stanford University, Stanford; and Veterans Affairs Palo Alto Health Care System, Palo Alto; 3Department of Health, Research & Policy, Stanford University, Stanford, California; and 4Bracco Suisse SA, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Tranquart","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine; 2Departments of Pathology, Stanford University, Stanford; and Veterans Affairs Palo Alto Health Care System, Palo Alto; 3Department of Health, Research & Policy, Stanford University, Stanford, California; and 4Bracco Suisse SA, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Tian","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine; 2Departments of Pathology, Stanford University, Stanford; and Veterans Affairs Palo Alto Health Care System, Palo Alto; 3Department of Health, Research & Policy, Stanford University, Stanford, California; and 4Bracco Suisse SA, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen K.","family":"Willmann","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine; 2Departments of Pathology, Stanford University, Stanford; and Veterans Affairs Palo Alto Health Care System, Palo Alto; 3Department of Health, Research & Policy, Stanford University, Stanford, California; and 4Bracco Suisse SA, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2013,3,14]]},"reference":[{"key":"2022061704055196100_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"2022061704055196100_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.7326\/0003-4819-137-5_Part_1-200209030-00012","article-title":"Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force","volume":"137","author":"Humphrey","year":"2002","journal-title":"Ann Intern Med"},{"key":"2022061704055196100_bib3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2214\/ajr.167.5.8911192","article-title":"Analysis of parenchymal density on mammograms in 1353 women 25\u201379 years old","volume":"167","author":"Stomper","year":"1996","journal-title":"AJR Am J Roentgenol"},{"key":"2022061704055196100_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1148\/radiol.2251011667","article-title":"Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations","volume":"225","author":"Kolb","year":"2002","journal-title":"Radiology"},{"key":"2022061704055196100_bib5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/jnci\/92.13.1081","article-title":"Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers","volume":"92","author":"Mandelson","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2022061704055196100_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJMoa062790","article-title":"Mammographic density and the risk and detection of breast cancer","volume":"356","author":"Boyd","year":"2007","journal-title":"N Engl J Med"},{"key":"2022061704055196100_bib7","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1001\/jama.299.18.2151","article-title":"Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer","volume":"299","author":"Berg","year":"2008","journal-title":"JAMA"},{"key":"2022061704055196100_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0887-2171(00)90027-1","article-title":"Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography","volume":"21","author":"Buchberger","year":"2000","journal-title":"Semin Ultrasound CT MR"},{"key":"2022061704055196100_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2214\/ajr.181.1.1810177","article-title":"Using sonography to screen women with mammographically dense breasts","volume":"181","author":"Crystal","year":"2003","journal-title":"AJR Am J Roentgenol"},{"key":"2022061704055196100_bib10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/1097-0142(19950815)76:4<626::AID-CNCR2820760413>3.0.CO;2-Z","article-title":"Malignant breast masses detected only by ultrasound. A retrospective review","volume":"76","author":"Gordon","year":"1995","journal-title":"Cancer"},{"key":"2022061704055196100_bib11","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2214\/ajr.180.6.1801675","article-title":"Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density","volume":"180","author":"Leconte","year":"2003","journal-title":"AJR Am J Roentgenol"},{"key":"2022061704055196100_bib12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1148\/radiol.2213010364","article-title":"Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue","volume":"221","author":"Kaplan","year":"2001","journal-title":"Radiology"},{"key":"2022061704055196100_bib13","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1200\/JCO.2009.24.4277","article-title":"Multimodality screening of high-risk women: a prospective cohort study","volume":"27","author":"Weinstein","year":"2009","journal-title":"J Clin Oncol"},{"key":"2022061704055196100_bib14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2011.01.027","article-title":"Targeted contrast-enhanced ultrasound: an emerging technology in abdominal and pelvic imaging","volume":"140","author":"Pysz","year":"2011","journal-title":"Gastroenterology"},{"key":"2022061704055196100_bib15","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.2174\/138161212800099900","article-title":"Targeted ultrasound imaging of cancer: an emerging technology on its way to clinics","volume":"18","author":"Kiessling","year":"2012","journal-title":"Curr Pharm Des"},{"key":"2022061704055196100_bib16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.crad.2010.02.013","article-title":"Molecular ultrasound imaging: current status and future directions","volume":"65","author":"Deshpande","year":"2010","journal-title":"Clin Radiol"},{"key":"2022061704055196100_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1021\/bc049898y","article-title":"Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging","volume":"16","author":"Klibanov","year":"2005","journal-title":"Bioconjug Chem"},{"key":"2022061704055196100_bib18","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J Clin Oncol"},{"key":"2022061704055196100_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/(SICI)1097-0215(19990621)84:3<293::AID-IJC16>3.0.CO;2-T","article-title":"Molecular mediators of tumor angiogenesis: enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer","volume":"84","author":"Kranz","year":"1999","journal-title":"Int J Cancer"},{"key":"2022061704055196100_bib20","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1053\/hupa.2002.126879","article-title":"Expression of the vascular endothelial growth factor receptor-2\/Flk-1 in breast carcinomas: correlation with proliferation","volume":"33","author":"Nakopoulou","year":"2002","journal-title":"Hum Pathol"},{"key":"2022061704055196100_bib21","first-page":"129","article-title":"Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells","volume":"12","author":"Price","year":"2001","journal-title":"Cell Growth Differ"},{"key":"2022061704055196100_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1066896909333511","article-title":"Angiogenesis in the progression of breast ductal proliferations","volume":"19","author":"Carpenter","year":"2011","journal-title":"Int J Surg Pathol"},{"key":"2022061704055196100_bib23","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1038\/sj.onc.1203970","article-title":"Transgenic mouse models of human breast cancer","volume":"19","author":"Hutchinson","year":"2000","journal-title":"Oncogene"},{"key":"2022061704055196100_bib24","first-page":"954","article-title":"Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease","volume":"12","author":"Guy","year":"1992","journal-title":"Mol Cell Biol"},{"key":"2022061704055196100_bib25","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0002-9440(10)63568-7","article-title":"Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases","volume":"163","author":"Lin","year":"2003","journal-title":"Am J Pathol"},{"key":"2022061704055196100_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1148\/radiol.10091858","article-title":"Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55)","volume":"256","author":"Pysz","year":"2010","journal-title":"Radiology"},{"key":"2022061704055196100_bib27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/RLI.0b013e3181ee8b83","article-title":"Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55","volume":"45","author":"Tardy","year":"2010","journal-title":"Invest Radiol"},{"key":"2022061704055196100_bib28","doi-asserted-by":"crossref","DOI":"10.1021\/bc9005688","article-title":"A phospholipid-PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeting heterodimer peptide for contrast-enhanced ultrasound imaging of angiogenesis","author":"Pillai","year":"2010","journal-title":"Bioconjug Chem"},{"key":"2022061704055196100_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/protein\/gzi049","article-title":"A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases","volume":"18","author":"Shrivastava","year":"2005","journal-title":"Protein Eng Des Sel"},{"key":"2022061704055196100_bib30","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1007\/s00330-011-2138-y","article-title":"Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38)","volume":"21","author":"Bzyl","year":"2011","journal-title":"Eur Radiol"},{"key":"2022061704055196100_bib31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1148\/radiol.11110323","article-title":"Quantification and monitoring of inflammation in murine inflammatory bowel disease with targeted contrast-enhanced US","volume":"262","author":"Deshpande","year":"2012","journal-title":"Radiology"},{"key":"2022061704055196100_bib32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1148\/radiol.2491072050","article-title":"Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice","volume":"249","author":"Willmann","year":"2008","journal-title":"Radiology"},{"key":"2022061704055196100_bib33","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1148\/radiol.2462070536","article-title":"US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice","volume":"246","author":"Willmann","year":"2008","journal-title":"Radiology"},{"key":"2022061704055196100_bib34","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1161\/01.CIR.102.22.2745","article-title":"Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes","volume":"102","author":"Lindner","year":"2000","journal-title":"Circulation"},{"key":"2022061704055196100_bib35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3348\/kjr.2010.11.6.589","article-title":"Supplementary screening sonography in mammographically dense breast: pros and cons","volume":"11","author":"Youk","year":"2010","journal-title":"Korean J Radiol"},{"key":"2022061704055196100_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1471-2407-9-335","article-title":"Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review","author":"Nothacker","year":"2009","journal-title":"BMC Cancer"},{"key":"2022061704055196100_bib37","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/jama.2012.388","article-title":"Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk","volume":"307","author":"Berg","year":"2012","journal-title":"JAMA"},{"key":"2022061704055196100_bib38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"2022061704055196100_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejso.2011.09.002","article-title":"The value of 18-FDG PET\/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan","volume":"38","author":"Garami","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"2022061704055196100_bib40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1148\/radiology.215.1.r00ap01267","article-title":"Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results","volume":"215","author":"Kuhl","year":"2000","journal-title":"Radiology"},{"key":"2022061704055196100_bib41","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/sj.bjc.6605196","article-title":"Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease","volume":"101","author":"Bluff","year":"2009","journal-title":"Br J Cancer"},{"key":"2022061704055196100_bib42","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7863\/jum.2008.27.6.855","article-title":"Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model","volume":"27","author":"Lee","year":"2008","journal-title":"J Ultrasound Med"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/73\/6\/1689\/2694674\/1689.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/73\/6\/1689\/2694674\/1689.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T10:15:02Z","timestamp":1655460902000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/73\/6\/1689\/586606\/Earlier-Detection-of-Breast-Cancer-with-Ultrasound"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,14]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,3,14]]},"published-print":{"date-parts":[[2013,3,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-12-3391","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6505290.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6505290","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22399365","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22399362","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22399365.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22399362.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,14]]}}}